Feb 14 2020

Pharmaceutical Company in India, Ahmedabad, Pharma Company in India, Cadila Pharmaceuticals, zydus pharmaceuticals.

#Zydus #pharmaceuticals


A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio

More than 38 APIs and intermediates including USFDA – certified products are manufactured at our ISO-9002 ISO14001 accredited facilities at Ankleshwar, India

Zydus pharmaceuticals

Zydus pharmaceuticals


Innovative products like ‘Polycap’ for cardiovascular disease, Risorine for Tuberculosis and Mycidac –C for lung cancer have been developed inhouse


Three state of the art manufacturing facilities in the state of Gujarat, Jammu (India) and Ethiopia are approved by all prominent international regulatory bodies, including USFDA

Zydus pharmaceuticals

About us

Zydus pharmaceuticals

Cadila Pharmaceuticals Limited, established in 1951 is one of the largest privately held pharmaceutical companies in India. An innovation and research focused company, we have been developing, manufacturing, selling and distributing pharmaceutical products across more than 45 therapeutic areas


Zydus pharmaceuticals

Mr. Indravadan A. Modi, Founder Chairman of Cadila Pharmaceuticals is called the Medicine Man of India. He was also the Champion of Indian Patents Act, 1970. He believed in making medicine affordable to the last man in the society.


Zydus pharmaceuticals

Cadila Pharmaceuticals with a significant presence in over 90 countries has a multicultural, multilingual and multinational workforce of more than 7000 employees including over two hundred people outside India in Africa, CIS, Japan and USA

Corporate identification No : U24231GJ1991PLC015132

Drug counterfeiting is a serious offence worldwide and claims many lives every year, while jeopardizing the lives of others. Today, counterfeiters are increasingly employing deceitful tactics to lure people with cheaper, but fatal drugs. Typically, counterfeiting today employs many mechanisms viz. absence of active ingredient, low levels of active ingredient, replacing safe drugs with poor-quality drugs and wrong packaging.

As a responsible corporate house, Cadila Pharmaceuticals Limited has started a drive against infringement or counterfeiting of its products. In this journey we urge you all to join and support us by reporting any type of counterfeiting of any of our products. You can mail us at [email protected] or call us on +91 – 2718 – 225001 and provide the details of the product mentioned below.

  • Product Name
  • Batch number of the product
  • Location where such issue found
  • Retailers/Whole Seller address and details
  • Indications that product has been counterfeited

Please mail picture/document facility and provide your contact details.

Written by admin